MEASUREMENT OF CIRCULATING MUTATION BURDEN

NCT06792721 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-07-08

No results posted yet for this study

Summary

Cancer-free women with a hereditary predisposition to breast and/or ovarian cancer

Conditions

  • Breast Carcinoma
  • Genetic Predisposition to Cancer
  • BRCA Mutation
  • cfMB
  • Mutation Burden

Interventions

GENETIC

Mutation Burden cfMB analysis

Blood samples will be collected (one time only)

Sponsors & Collaborators

  • Centre Francois Baclesse

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-04
Primary Completion
2027-07-15
Completion
2027-12-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06792721 on ClinicalTrials.gov